Continuous Renal Replacement Therapy Market Size, Share, Analysis, Trends and Forecast - 2022

From: MarketsandMarkets
Published: Tue Sep 25 2018


Rising number of acute kidney injury to drive market demand for continuous renal replacement therapy market; reaching a value of USD 1.53 billion by 2022

The global continuous renal replacement therapy market has been segmented on the basis of product, modality, and region. Based on product, the dialysates and replacement fluids segment commanded the largest share of the global CRRT market in 2016. This large market share is mainly attributed to factors such as high volume requirement of dialysates & replacement fluids, high cost of these components, and development & commercialization of novel renal replacement solutions.

The global CRRT market is estimated to reach USD 1.53 billion by 2022; growing at a CAGR of 7.0% during the forecast period. Increasing prevalence of AKI and renal disorders, growing number of ICU patients, rapid growth in the aging population, and clinical advantages of CRRT over intermittent blood purification techniques are some key factors propelling the growth of this market.

In 2016, Europe held the largest share of the market. However, the developing Asia-Pacific countries including China and India are expected to emerge as the new revenue-generating regions for prominent market players during 2017-2022. The growth of this Asia-Pacific market is attributed to the growing patient population, increasing sepsis incidence, increasing prevalence of hypertension and diabetes (which are the major causes for developing AKI), high use of CRRT in Australia and Japan, improving healthcare expenditure, and increasing accessibility to CRRT for AKI treatment.

PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=246917088

In 2016, Baxter International Inc. (U.S.) held the leading position in the market. Over the past three years, the company has adopted product launches & enhancements, strategic acquisitions, and market expansion as its key business strategies to ensure its dominance in this market. Fresenius Medical Care AG & Co. KGAA (Germany), Nikkiso Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Nxstage Medical, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Bellco S.R.L. (Italy) Infomed SA (Switzerland), Medica S.p.A (Italy), Medical Components, Inc. (U.S.), and Toray Medical Company Limited (Japan) were few other key players operating in the continuous renal replacement therapy market.

Growing demand of hemofilters to drive the global CRRT market to reach USD 1.53 billion by 2022

Hemofilters or artificial kidneys are one of the major components in a CRRT system. These filters usually contain a semipermeable membrane in a hollow-fiber design. This design enables blood to flow inside the hollow fibers and, at the same time, allows the dialysate to flow outside the fibers. The membrane type and surface area help to determine solute and fluid removal during a CRRT procedure.

The hemofilters market is projected to reach largest market share of overall CRRT market for disposables by 2022, largely due to development of new hemofilters, the rise in the number of CRRT procedures, and growing focus of manufacturers on expanding their distribution channels. Large number of clinical studies is currently underway to understand the effects of hemofilters on anticoagulating agents during CRRT procedures in critically ill patients are likely to propel further growth of the hemofilters during the forecast period.

The implementations of localized manufacturing across emerging markets (such as China, India, and Brazil) by major market players are expected to increase the availability of hemofilters at competitive prices.

More Info: https://www.marketsandmarkets.com/Market-Reports/continuous-renal-replacement-therapy-market-246917088.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/continuous-renal-replacement-therapy-market.asp
Company: MarketsandMarkets
Contact Name: 1marketsandmarkets
Contact Email: debashish.roy@marketsandmarkets.com
Contact Phone: 1-888-600-6441

Visit website »